申请人:Pfizer Inc.
公开号:US20030105097A1
公开(公告)日:2003-06-05
The invention provides compounds of formula (I)
1
wherein R
1
is optionally substituted C
1-6
alkyl, optionally substituted carbocyclyl, optionally substituted heterocyclyl, C
1-6
alkoxy, —NR
2
R
3
or —NR
4
SO
2
R
5
; n is 2 to 6; X is oxygen, sulfur or —CH
2
—; Y is C
1-6
alkyl which may be branched- or straight-chain, and may be independently substituted by one or more halo, C
1-4
alkoxy, hydroxy or C
3-7
cycloalkyl; wherein the linkage —(CH
2
)
n
— and the linkage when X is —CH
2
—, may be substituted by C
1-4
alkyl, C
1-4
haloalkyl, hydroxy, C
1-4
alkoxy, C
1-4
haloalkoxy, hydroxyC
1-4
alkyl, C
1-4
alkoxyC
1-4
alkyl, C
1-4
haloalkoxyC
1-4
alkyl, C
3-7
cycloalkyl or C
3-7
cycloalkylC
1-4
alkyl. The compounds of the invention are useful in the treatment of sexual dysfunction, particularly female sexual dysfunction.
本发明提供了公式(I)的化合物,其中R1是可选的取代C1-6烷基,可选的取代的碳环烷基,可选的取代的杂环烷基,C1-6烷氧基,-NR2R3或-NR4SO2R5; n为2到6; X为氧、硫或-CH2-; Y为C1-6烷基,可以是分支或直链,可以独立地被一个或多个卤素、C1-4烷氧基、羟基或C3-7环烷基取代; 其中链-(CH2)n-和链当X为-CH2-时,可以被C1-4烷基、C1-4卤代烷基、羟基、C1-4烷氧基、C1-4卤代烷氧基、羟基C1-4烷基、C1-4烷氧基C1-4烷基、C1-4卤代烷氧基C1-4烷基、C3-7环烷基或C3-7环烷基C1-4烷基取代。本发明的化合物可用于治疗性功能障碍,特别是女性性功能障碍。